Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy.
2007
Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
39
References
35
Citations
NaN
KQI